Home

Treatment

Read time: 4 min

Satellite symposium

Experts’ perspectives on managing chronic migraine in their own clinical practice

Three experts from different countries provided perspectives on their own clinical practice...

Read time: 2 min

Congress highlights

Strategies to improve cognition in schizophrenia

Cognition depends upon a complex interaction of brain regions and is often impaired in...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Targeting tau – homing-in on effective therapies in Alzheimer’s disease

Several new and highly promising therapeutics for the management and possible prevention of...

Read time: 2 min

Congress highlights

Interventions to improve real-life functioning

Accurate assessment of neurocognition and social cognition and personalized cognitive training and...

Read time: 2 min

Congress highlights

Prevention of medication overuse in clinical practice

"Medication overuse occurs in nearly 75% of patients with chronic migraine who are correctly...

Read time: 2 min

Congress highlights

New insights from a poster at IHC2021 on how patients respond when switched from one anti-CGRP monoclonal antibody to another

What is the effect of switching to a second anti-CGRP monoclonal antibody when migraine fails to...

Read time: 3 min

Satellite symposium

The spectrum of medication overuse headache risk factors and treatments

What makes migraine worse? A plenary session at the AHS hybrid meeting 2022 addressed exactly this...

Read time: 3 min

Congress highlights

Predicting antidepressant response – problems and promises

Precision medicine is a burgeoning field and has the potential to aid diagnosis and tailor...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country